Our data indicated that a high expression of this lncRNA is correlated with a larger tumor size and a later stage of tumor development in breast cancer patients, indicating that SPRY4-IT1 may be a promising prognostic biomarker for breast cancer patients. Here, SPRY4 is linked to breast cancer.